B

Brainstorm Research | Miami, FL

Research site

(Unclaimed)

Location

9055 SW 87th Avenue Suite 101, Miami, Florida, United States of America

Site insights

Top conditions

Top treatments

Simufilam

Aducanumab

LY3002813

Benfotiamine

AR1001

Cenobamate

MTX101

BOTOX

Donanemab

Eptinezumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 14 total trials

A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications

The main goal of this trial is to learn whether eptinezumab improves migraine symptoms and quality of life of participants with migraine who did not...

Active, not recruiting

Migraine

Drug: Eptinezumab

Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type

This study will be conducted to evaluate the efficacy, safety, tolerability, and pharmacokinetics of masupirdine compared to placebo for the treatmen...

Enrolling

Agitation

Alzheimer's Type Dementia

Drug: Masupirdine 100 mg

Drug: Placebo

Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD)

This AR1001-ADP3-US01 protocol is a double-blind, randomized, placebo-controlled, multi- center, parallel-group comparison pivotal Phase 3 study to e...

Active, not recruiting

Alzheimer Disease

Drug: Placebo

Drug: AR1001

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

The purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of moderate or severe migraine in chil...

Enrolling

Pediatric Migraine

Drug: Rimegepant/BHV3000

Drug: Matching placebo